跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 75 条关于
“inflammasomes”
全部
75
临床试验
48
药物
10
机构
0
资讯
17
去年
ZyVersa Highlights Data on Inflammasome Inhibition for Type 2 Diabetes Prevention
去年
Inflammasome Therapeutics' K8 Implant Reduces Geographic Atrophy Lesion Growth by 53% in Phase I Trial
去年
ZyVersa's IC 100 Shows Promise as Disease-Modifying Treatment for Parkinson's Disease
去年
HIV Drugs Show Promising Potential to Reduce Alzheimer's Risk by Up to 13% Annually
去年
Halia Therapeutics Completes Enrollment in Phase 2a Trial of Novel NLRP3 Inflammasome Inhibitor for Myelodysplastic Syndrome
11个月前
Precision Immunomodulation Emerges as Key Strategy to Balance Inflammation and Restore Tissue Homeostasis
去年
HIV Drug Lamivudine Shows Promise as Oral Treatment for Diabetic Macular Edema in Clinical Trial
7年前
FDA Approves Resmetirom (Rezdiffra) for Treating MASH and Associated Fibrosis
10个月前
Inflammasome Therapeutics Partners with Mass General's Healey ALS Center to Test Novel Neuroinflammation Drug K9
去年
Oncolytic Virus-Immune Checkpoint Inhibitor Combinations Show Promise in Melanoma Treatment
第 1 页,共 2 页
上一页
下一页